Risk factor
Meaningful price volatility
Profitability factor
Favourable analyst view
About
Dentium Co.,Ltd. manufactures and sells dental implant products worldwide. Its dental implant systems include superline, implantium, simpleline II, slimline, overdenture system, NR line, and implantium II. The company also provides surgical instruments, such as surgical, drill stopper, sinus, osteotome, trephine bur, prosthetic, planning, restorative, and help kits, as well as harvest drills, sinus elevators, GBR systems, surgical guides, temporary shells, white seals, TN brushes, and guide systems; regeneration products, including bone grafts, membranes, and tissue regeneration products; and digital dentistry products. In addition, it offers lab products; and iCT motors and injections. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. The company was founded in 2000 and is headquartered in Seoul, South Korea.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBI
Target Price
The average target price of 145720.KS is 75399 and suggests 41% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell